A plea seeking a direction to restrain the Centre from conducting any further clinical trials of rotavirus vaccine in India has been dismissed by the Delhi High Court. The court said that the petition "does not deserve to be taken cognizance as a Public Interest Litigation."
Rotavirus vaccine protects children from viruses, which are the leading cause of severe diarrhea among infants and young children.
Keeping Rotavirus at Bay
Virus such as influenza via specific characteristics of viral ribonucleic acid can be detected by our immunosensory system.
Advertisement
A bench of Chief Justice G Rohini and Justice Jayant Nath said no case of violation of any statutory provision is made out in the present petition and no case is also made out to show that disclosure of the segregated data of clinical trial is essential in public interest.
"We, therefore, find substance in the submission of the Additional Solicitor General (ASG) that the petition is misconceived and motivated with private interest. For the aforesaid reasons, the petition does not deserve to be taken cognizance as a Public Interest Litigation," the bench said.
![Novel Treatment to Stop Rotavirus Infection]( "Novel Treatment to Stop Rotavirus Infection")
Rotavirus is transmitted by the faecal-oral route, via contact with contaminated hands, surfaces and objects, and possibly by the respiratory route.
The court's order came on a plea filed by Dr Jacob Puliyel, a member of National Technical Advisory Group on Immunization (NTAGI) seeking to restrain the government from moving on to phase IV trials in which over one lakh children would be administered the vaccine.
Puliyel in his plea has also sought directions to the government to provide complete data of the multi-center clinical trials of the vaccine.
The bench said NTAGI, which is the highest technical advisory body in the country on immunization on on being satisfied about its efficacy and safety, has recommended to introduce the vaccine in question for National Immunization Program.
"In the circumstances, we do not find any substance in the contention of the petitioner that in the absence of the information about the number of cases of intussusceptions in clinical trial at one of the centers, the Government cannot be allowed to proceed to take up Phase-IV study of the vaccine," the bench said.
Source: PTI
Novel Treatment to Stop Rotavirus Infection
Rotavirus is transmitted by the faecal-oral route, via contact with contaminated hands, surfaces and objects, and possibly by the respiratory route.
Advertisement
The court's order came on a plea filed by Dr Jacob Puliyel, a member of National Technical Advisory Group on Immunization (NTAGI) seeking to restrain the government from moving on to phase IV trials in which over one lakh children would be administered the vaccine.
Puliyel in his plea has also sought directions to the government to provide complete data of the multi-center clinical trials of the vaccine.
The bench said NTAGI, which is the highest technical advisory body in the country on immunization on on being satisfied about its efficacy and safety, has recommended to introduce the vaccine in question for National Immunization Program.
"In the circumstances, we do not find any substance in the contention of the petitioner that in the absence of the information about the number of cases of intussusceptions in clinical trial at one of the centers, the Government cannot be allowed to proceed to take up Phase-IV study of the vaccine," the bench said.
Source: PTI
Novel Method to Prevent Rotavirus Infection Identified
A Georgia State University research team says that activation of the innate immune system with the bacterial protein flagellin could prevent and cure rotavirus infection.
Advertisement
 Study Confirms Rotavirus Vaccine can Save Millions of Children from DyingRotavirus is the most common cause of diarrhea, the second largest killer of children across the world, and vaccines to contain the virus can change the situation dramatically, a study has confirmed. | Advertisement
|
Advertisement
Recommended Readings
Latest Indian Health News
The Rs 1,500 crore 'Chief Minister Health at Doorstep' program aims to cut expenses and conduct blood tests for those aged 60+.
In Bihar, a mysterious ailment named "Langda fever" by locals has emerged, causing patients to recover from fever but struggle to walk due to joint pain.
Upon analyzing the years of life lost due to cancer, the team discovered that the four avoidable risk factors led to an annual loss of over 30 million years of life.
Over the past three to four weeks in Delhi, there has been an increase of 20-30% in patients with recurring cough and upper respiratory tract infections.
Premature infants with gastrointestinal complications and metabolic disorders stand to benefit the most from this Lactarium initiative.